Intravesical BCG Administration to Patients With Invasive Bladder Cancer

NCT02365207 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Poor accrual of subjects and lack of funding

Conditions

Bladder Cancer

Interventions

DRUG: BCG strain of Mycobacterium bovis

Sponsor

The University of Texas Health Science Center at San Antonio